This Article Full Text Full Text (PDF) Other Versions of this Article: AEM.02439-06v1 73/6/1697    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jain, N. Articles by Fries, B. C. Search for Related Content PubMed PubMed Citation Articles by Jain, N. Articles by Fries, B. C. Agricola Articles by Jain, N. Articles by Fries, B. C.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, March 2007, p. 1697-1703, Vol. 73, No. 6
0099-2240/07/$08.00+0     doi:10.1128/AEM.02439-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Biofilm Formation by and Antifungal Susceptibility of Candida Isolates from Urine

Department of Medicine and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York,¹ Infectious Disease Division, Montefiore Hospital and Albert Einstein College of Medicine, Bronx, New York,² Department of Pathology, Montefiore Medical Center, Bronx, New York³

Received 17 October 2006/ Accepted 8 January 2007

Biofilm formation (BF) in the setting of candiduria has not been well studied. We determined BF and MIC to antifungals in Candida spp. isolates grown from urine samples of patients and performed a retrospective chart review to examine the correlation with risk factors. A total of 67 Candida spp. isolates were grown from urine samples from 55 patients. The species distribution was C. albicans (54%), C. glabrata (36%), and C. tropicalis (10%). BF varied greatly among individual Candida isolates but was stable in sequential isolates during chronic infection. BF also depended on the growth medium and especially in C. albicans was significantly enhanced in artificial urine (AU) compared to RPMI medium. In nine of the C. albicans strains BF was 4- to 10-fold higher in AU, whereas in three of the C. albicans strains and two of the C. glabrata strains higher BF was measured in RPMI medium than in AU. Determination of the MICs showed that planktonic cells of all strains were susceptible to amphotericin B (AMB) and caspofungin (CASPO) and that three of the C. glabrata strains and two of the C. albicans strains were resistant to fluconazole (FLU). In contrast, all biofilm-associated adherent cells were resistant to CASPO and FLU. The biofilms of 14 strains (28%) were sensitive to AMB (MIC₅₀ of <1 µg/ml). Correlation between degree of BF and MIC of AMB was not seen in RPMI grown biofilms but was present when grown in AU. A retrospective chart review demonstrated no correlation of known risk factors of candiduria with BF in AU or RPMI. We conclude that BF is a stable characteristic of Candida strains that varies greatly among clinical strains and is dependent on the growth medium. Resistance to AMB is associated with higher BF in AU, which may represent the more physiologic medium to test BF. Future studies should address whether in vitro BF can predict treatment failure in vivo.

Published ahead of print on 19 January 2007.

This article has been cited by other articles:

• Seneviratne, C. J., Jin, L. J., Samaranayake, Y. H., Samaranayake, L. P. (2008). Cell Density and Cell Aging as Factors Modulating Antifungal Resistance of Candida albicans Biofilms. Antimicrob. Agents Chemother. 52: 3259-3266 [Abstract] [Full Text]  
• Tumbarello, M., Posteraro, B., Trecarichi, E. M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., Cauda, R., Sanguinetti, M. (2007). Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia. J. Clin. Microbiol. 45: 1843-1850 [Abstract] [Full Text]